bar_chartArbutus Biopharma Corporation
ABUS | Healthcare | Biotechnology
bar_chartPerformance
bar_chartPerformance(Quarter)
bar_chartCash Flow
bar_chartCash Flow(Quarter)
bar_chartInstitutional Holders
| Holder | % Out | Shares |
|---|---|---|
| Blackrock Inc. | 4.15% | 6,166,349 |
| Vanguard Group, Inc. (The) | 3.06% | 4,555,494 |
| Millennium Management LLC | 2.04% | 3,039,185 |
| RTW Investments LP | 1.68% | 2,504,493 |
| Nuveen Asset Management | 1.35% | 2,011,809 |
| Hudson Bay Capital Management Lp | 1.21% | 1,805,700 |
| State Street Corporation | 1.13% | 1,683,829 |
| Geode Capital Management, LLC | 1.12% | 1,669,624 |
| Advisor Group, Inc. | 0.92% | 1,364,894 |
| Brookfield Asset Management Inc. | 0.8% | 1,192,889 |
bar_chartMutual Fund Holders
| Holder | % Out | Shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.81% | 2,697,043 |
| iShares Russell 2000 ETF | 1.26% | 1,871,214 |
| TIAA-CREF Funds-Quant Small Cap Equity Fund | 1.0% | 1,481,450 |
| Vanguard Extended Market Index Fund | 0.91% | 1,355,751 |
| iShares NASDAQ Biotechnology ETF | 0.57% | 852,389 |
| iShares Russell 2000 Value ETF | 0.52% | 776,972 |
| Fidelity Extended Market Index Fund | 0.35% | 512,976 |
| Primecap Odyssey Aggressive Growth Fund | 0.32% | 470,000 |
| Fidelity Small Cap Index Fund | 0.28% | 413,373 |
| Advanced Series Tr-AST/Prudential Growth Allocation Port | 0.24% | 350,700 |